Skip to main content
Caplight Logo









Hubei NewZongke Viral Disease Control Bio-Tech Ltd.

Hubei NewZongke Viral Disease Control Bio-Tech Ltd.

Private
WuhanHealthcare & Life Scienceshttp://hbnzk.com/

Last Round

Series B

Oct 10, 2024

Total Funding Raised

$8.41M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Hubei NewZongke Viral Disease Control Bio-Tech Ltd. is a biotechnology company that provides precision detection technology solutions, including open instrument platforms, fluorescent coded microspheres, and reagent solutions for life sciences and healthcare.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

flow cytometryin-vitro diagnosticsIVDliquid chip technologymultiplex detectiondiagnostic reagentsfluorescent microspheresbiomedical researchclinical laboratory equipmentlab automationbiotech hardwaremultiplex assayprecision medicineprotein detectionnucleic acid detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hubei NewZongke Viral Disease Control Bio-Tech Ltd. Comparables

Compare Hubei NewZongke Viral Disease Control Bio-Tech Ltd. with similar companies based on industry and business-model similarity.

Hubei NewZongke Viral Disease Control Bio-Tech Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wellgrow Technology
87%
Beijing Challen Biotechnology Co., Ltd.
86%
Suzhou VDO Biotech Co., Ltd.
84%

Hubei NewZongke Viral Disease Control Bio-Tech Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 10, 2024
Corporate FundingSep 18, 2024
Series ANov 1, 2018
AngelJun 28, 2016

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 81% MoM.

  • Oct 10, 2024

    $4M round led by 科来思(深圳)科技有限公司

Hubei NewZongke Viral Disease Control Bio-Tech Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hubei NewZongke Viral Disease Control Bio-Tech Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hubei NewZongke Viral Disease Control Bio-Tech Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWuhan
Employee Range1
Year Founded2010
Last FundingOct 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?